This study identified seven distinct area-level deprivation trajectories in Northern Ireland from 2010 to 2016 and found that upward social mobility was generally linked to reduced risk of poor health outcomes, while downward mobility increased such risks compared to stable deprivation groups. Notably, a dose-response relationship emerged between lower deprivation at the endpoint and better health outcomes, though one upwardly mobile group exhibited unexpectedly high health risks, underscoring the complexity of social mobility's impact on health.

The article reports widespread exposure to the endocrine-disrupting chemical di-n-hexyl phthalate (DnHxP) in Danish pregnant women, children, and adults, with significantly higher exposures during the summer months, likely due to contamination of the UV-filter diethylamino hydroxybenzyl hexyl benzoate (DHHB) in sunscreen products

World map with SDG icons and people

Recognising our customer's efforts to advance the United Nations Sustainable Development Goals.

Elsevier,

Journal of Endometriosis and Uterine Disorders, 2025, 100124

This study examined racial/ethnic disparities in the surgical management of endometriosis using data from the National Survey of Family Growth (NSFG) 2017-2019 cycle.�

This chapter provides a comprehensive overview of Prader-Willi syndrome (PWS), emphasizing its genetic basis, clinical features, and the importance of early diagnosis and multidisciplinary care. It aligns with SDG 3 (Good Health and Well-being) by promoting precision medicine and interventions to improve health outcomes, and SDG 10 (Reduced Inequalities) by advocating equitable access to specialized care and innovative treatments for individuals with PWS.

This study investigated the prevalence and impact of auditory agnosia for environmental sounds in individuals with Alzheimer’s disease (AD), finding that over half exhibited signs of this central auditory dysfunction along with a high rate of unrecognized peripheral hearing loss. Although these factors appeared independent and showed limited direct effect on measured quality of life, possibly due to sheltered living environments and lack of patient awareness, they jointly contribute to daily functional decline, highlighting the importance of early hearing assessment and intervention in AD management.
The article discusses the need for and challenges of developing combination therapies for Alzheimer's disease, given the complex and multifactorial nature of the disease. As of 2024, there were 21 combination trials in the pipeline, primarily involving repurposed agents targeting processes like inflammation, senescence, and amyloid-tau interactions. Key challenges include distinguishing individual drug effects and managing the operational complexity of combination trials.f
Elsevier,

Journal of Prevention of Alzheimer's Disease, Volume 12, 1 June 2025

This article provides a narrative review of the relationships between modifiable lifestyle factors and plasma biomarkers of Alzheimer's disease (AD). The key findings are that better nutrition, more physical activity, and good sleep quality are associated with more favorable plasma AD biomarker profiles, potentially reflecting less cerebral AD pathology.
The article discusses the potential of glucagon-like peptide-1 (GLP-1) receptor agonists (GRA) as novel therapeutic agents for neurodegenerative diseases (NDs) like Alzheimer's disease (AD) and Parkinson's disease (PD). GRA have shown promising effects in modulating neuroinflammation, oxidative stress, mitochondrial and autophagic functions, and protein misfolding in preclinical studies. Clinical trials have demonstrated that GRA like exenatide, liraglutide, and lixisenatide can improve motor deficits in PD and cognitive function in AD patients.
The article discusses the critical role of the mitochondrial contact site and cristae organizing system (MICOS) complex in the pathogenesis of Alzheimer's disease (AD). It highlights how MICOS abnormalities, including subunit dysfunction and interactions with disease-associated proteins, to hallmark AD pathologies such as amyloid-β accumulation, neurofibrillary tangle formation, and neuronal apoptosis. The article suggests that targeting MICOS subunits with pharmacological interventions may provide novel therapeutic insights for AD treatment.

Pages